Aytu BioPharma, Inc.: Aytu BioPharma Announces Highest Weekly Adzenys XR-ODT Prescriptions Generated Since Inception of RxConnect
Adzenys XR-ODT Total Prescription (TRx) Unit Growth Driven by a Combination of Continued Sales Force Execution, Leveraging of the Aytu RxConnect Patient Support Program, and a Positive Response to the
Source: finanznachrichten.de